Global Retinal Biologics Market Research Report 2023

Report ID: 1887310 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Retinal Biologics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Macular Degeneration
        1.2.3 Diabetic Retinopathy
        1.2.4 Diabetic Macular Edema
        1.2.5 Uveitis
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Retinal Biologics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Retinal Biologics Market Perspective (2017-2028)
    2.2 Retinal Biologics Growth Trends by Region
        2.2.1 Retinal Biologics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Retinal Biologics Historic Market Size by Region (2017-2022)
        2.2.3 Retinal Biologics Forecasted Market Size by Region (2023-2028)
    2.3 Retinal Biologics Market Dynamics
        2.3.1 Retinal Biologics Industry Trends
        2.3.2 Retinal Biologics Market Drivers
        2.3.3 Retinal Biologics Market Challenges
        2.3.4 Retinal Biologics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Retinal Biologics Players by Revenue
        3.1.1 Global Top Retinal Biologics Players by Revenue (2017-2022)
        3.1.2 Global Retinal Biologics Revenue Market Share by Players (2017-2022)
    3.2 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Retinal Biologics Revenue
    3.4 Global Retinal Biologics Market Concentration Ratio
        3.4.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2021
    3.5 Retinal Biologics Key Players Head office and Area Served
    3.6 Key Players Retinal Biologics Product Solution and Service
    3.7 Date of Enter into Retinal Biologics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Biologics Breakdown Data by Type
    4.1 Global Retinal Biologics Historic Market Size by Type (2017-2022)
    4.2 Global Retinal Biologics Forecasted Market Size by Type (2023-2028)
5 Retinal Biologics Breakdown Data by Application
    5.1 Global Retinal Biologics Historic Market Size by Application (2017-2022)
    5.2 Global Retinal Biologics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Retinal Biologics Market Size (2017-2028)
    6.2 North America Retinal Biologics Market Size by Country (2017-2022)
    6.3 North America Retinal Biologics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Retinal Biologics Market Size (2017-2028)
    7.2 Europe Retinal Biologics Market Size by Country (2017-2022)
    7.3 Europe Retinal Biologics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Retinal Biologics Market Size (2017-2028)
    8.2 Asia-Pacific Retinal Biologics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Retinal Biologics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Retinal Biologics Market Size (2017-2028)
    9.2 Latin America Retinal Biologics Market Size by Country (2017-2022)
    9.3 Latin America Retinal Biologics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Retinal Biologics Market Size (2017-2028)
    10.2 Middle East & Africa Retinal Biologics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Retinal Biologics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Spark Therapeutics, Inc
        11.1.1 Spark Therapeutics, Inc Company Detail
        11.1.2 Spark Therapeutics, Inc Business Overview
        11.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction
        11.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2017-2022)
        11.1.5 Spark Therapeutics, Inc Recent Development
    11.2 F. Hoffmann-La Roche Ltd
        11.2.1 F. Hoffmann-La Roche Ltd Company Detail
        11.2.2 F. Hoffmann-La Roche Ltd Business Overview
        11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction
        11.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2017-2022)
        11.2.5 F. Hoffmann-La Roche Ltd Recent Development
    11.3 Regeneron Pharmaceuticals, Inc
        11.3.1 Regeneron Pharmaceuticals, Inc Company Detail
        11.3.2 Regeneron Pharmaceuticals, Inc Business Overview
        11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction
        11.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2017-2022)
        11.3.5 Regeneron Pharmaceuticals, Inc Recent Development
    11.4 AbbVie Inc
        11.4.1 AbbVie Inc Company Detail
        11.4.2 AbbVie Inc Business Overview
        11.4.3 AbbVie Inc Retinal Biologics Introduction
        11.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2017-2022)
        11.4.5 AbbVie Inc Recent Development
    11.5 Johnson & Johnson Services, Inc
        11.5.1 Johnson & Johnson Services, Inc Company Detail
        11.5.2 Johnson & Johnson Services, Inc Business Overview
        11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction
        11.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2017-2022)
        11.5.5 Johnson & Johnson Services, Inc Recent Development
    11.6 Amgen Inc
        11.6.1 Amgen Inc Company Detail
        11.6.2 Amgen Inc Business Overview
        11.6.3 Amgen Inc Retinal Biologics Introduction
        11.6.4 Amgen Inc Revenue in Retinal Biologics Business (2017-2022)
        11.6.5 Amgen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Retinal Biologics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Macular Degeneration
    Table 3. Key Players of Diabetic Retinopathy
    Table 4. Key Players of Diabetic Macular Edema
    Table 5. Key Players of Uveitis
    Table 6. Key Players of Others
    Table 7. Global Retinal Biologics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Retinal Biologics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Retinal Biologics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Retinal Biologics Market Share by Region (2017-2022)
    Table 11. Global Retinal Biologics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Retinal Biologics Market Share by Region (2023-2028)
    Table 13. Retinal Biologics Market Trends
    Table 14. Retinal Biologics Market Drivers
    Table 15. Retinal Biologics Market Challenges
    Table 16. Retinal Biologics Market Restraints
    Table 17. Global Retinal Biologics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Retinal Biologics Market Share by Players (2017-2022)
    Table 19. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2021)
    Table 20. Ranking of Global Top Retinal Biologics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Retinal Biologics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Retinal Biologics Product Solution and Service
    Table 24. Date of Enter into Retinal Biologics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Retinal Biologics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Retinal Biologics Revenue Market Share by Type (2017-2022)
    Table 28. Global Retinal Biologics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Retinal Biologics Revenue Market Share by Type (2023-2028)
    Table 30. Global Retinal Biologics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Retinal Biologics Revenue Market Share by Application (2017-2022)
    Table 32. Global Retinal Biologics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Retinal Biologics Revenue Market Share by Application (2023-2028)
    Table 34. North America Retinal Biologics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Retinal Biologics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Retinal Biologics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Retinal Biologics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Retinal Biologics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Retinal Biologics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Retinal Biologics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Retinal Biologics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Retinal Biologics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Retinal Biologics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Spark Therapeutics, Inc Company Detail
    Table 45. Spark Therapeutics, Inc Business Overview
    Table 46. Spark Therapeutics, Inc Retinal Biologics Product
    Table 47. Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
    Table 48. Spark Therapeutics, Inc Recent Development
    Table 49. F. Hoffmann-La Roche Ltd Company Detail
    Table 50. F. Hoffmann-La Roche Ltd Business Overview
    Table 51. F. Hoffmann-La Roche Ltd Retinal Biologics Product
    Table 52. F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
    Table 53. F. Hoffmann-La Roche Ltd Recent Development
    Table 54. Regeneron Pharmaceuticals, Inc Company Detail
    Table 55. Regeneron Pharmaceuticals, Inc Business Overview
    Table 56. Regeneron Pharmaceuticals, Inc Retinal Biologics Product
    Table 57. Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
    Table 58. Regeneron Pharmaceuticals, Inc Recent Development
    Table 59. AbbVie Inc Company Detail
    Table 60. AbbVie Inc Business Overview
    Table 61. AbbVie Inc Retinal Biologics Product
    Table 62. AbbVie Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
    Table 63. AbbVie Inc Recent Development
    Table 64. Johnson & Johnson Services, Inc Company Detail
    Table 65. Johnson & Johnson Services, Inc Business Overview
    Table 66. Johnson & Johnson Services, Inc Retinal Biologics Product
    Table 67. Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
    Table 68. Johnson & Johnson Services, Inc Recent Development
    Table 69. Amgen Inc Company Detail
    Table 70. Amgen Inc Business Overview
    Table 71. Amgen Inc Retinal Biologics Product
    Table 72. Amgen Inc Revenue in Retinal Biologics Business (2017-2022) & (US$ Million)
    Table 73. Amgen Inc Recent Development
    Table 74. Research Programs/Design for This Report
    Table 75. Key Data Information from Secondary Sources
    Table 76. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Retinal Biologics Market Share by Type: 2021 VS 2028
    Figure 2. Macular Degeneration Features
    Figure 3. Diabetic Retinopathy Features
    Figure 4. Diabetic Macular Edema Features
    Figure 5. Uveitis Features
    Figure 6. Others Features
    Figure 7. Global Retinal Biologics Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Retinal Biologics Report Years Considered
    Figure 12. Global Retinal Biologics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Retinal Biologics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Retinal Biologics Market Share by Region: 2021 VS 2028
    Figure 15. Global Retinal Biologics Market Share by Players in 2021
    Figure 16. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Retinal Biologics Revenue in 2021
    Figure 18. North America Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Retinal Biologics Market Share by Country (2017-2028)
    Figure 20. United States Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Retinal Biologics Market Share by Country (2017-2028)
    Figure 24. Germany Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Retinal Biologics Market Share by Region (2017-2028)
    Figure 32. China Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Retinal Biologics Market Share by Country (2017-2028)
    Figure 40. Mexico Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Retinal Biologics Market Share by Country (2017-2028)
    Figure 44. Turkey Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Retinal Biologics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Spark Therapeutics, Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
    Figure 47. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinal Biologics Business (2017-2022)
    Figure 48. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
    Figure 49. AbbVie Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
    Figure 50. Johnson & Johnson Services, Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
    Figure 51. Amgen Inc Revenue Growth Rate in Retinal Biologics Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc
Frequently Asked Questions
Retinal Biologics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Retinal Biologics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Retinal Biologics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports